Emanuele Ostuni

CEO at ARTBIO Inc.

Speaker

Emanuele is the founding CEO of ARTBIO – he worked closely with Roy Larsen and our investors to build the company and its business model. Previously, he was Head of Europe for Cell and Gene Therapies at Novartis Oncology, where he oversaw all commercialization aspects of Kymriah in Europe, the first FDAapproved CAR-T cell therapy. Emanuele was with Novartis since 2012 in various executive roles in Sandoz where he worked globally, in Eastern Europe, and in Romania. Previously he held positions at Nano Terra, McKinsey & Co., and Surface Logix. Emanuele was the co-founder of Enumeral Biomedical and served on its board of directors through its public listing in 2014. He served on the SAB of Anixa Biosciences and currently serves on the SAB of Elicio Therapeutics. Emanuele earned a Ph.D. in Physical Chemistry from Harvard University and bachelor's and master's degrees in Chemistry from Georgetown University